The chart below shows how MMS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MMS sees a +1.76% change in stock price 10 days leading up to the earnings, and a +2.74% change 10 days following the report. On the earnings day itself, the stock moves by -1.10%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q1 2025 Revenue Growth: Revenue of $1.40 billion for Q1 2025 represents a 5.7% year-over-year growth, with 6.3% organic growth driven primarily by the US Federal Services segment.
Federal Services Revenue Growth: US Federal Services segment revenue increased 15.3% to $781 million, with an operating income margin of 12.7%, up from 10.2% in the prior year period.
Strong Demand Indicators: Total signed awards in Q1 2025 amounted to $2.1 billion, resulting in a book-to-bill ratio of approximately 1.5 times, indicating strong demand and contract activity.
Share Repurchase Program Expansion: The Board of Directors authorized a $200 million increase to the share repurchase program, with approximately $290 million deployed in share repurchases since the fiscal year start.
Q1 Adjusted EPS Increase: Adjusted EPS for Q1 2025 was reported at $1.61, an increase from $1.34 in the prior year period, reflecting improved profitability and operational efficiency.
Negative
Earnings Per Share Shortfall: Maximus, Inc. reported an EPS of $0.69, significantly missing expectations of $1.39, indicating a substantial shortfall in profitability.
US Services Revenue Decline: The US Services segment experienced a revenue decline of 7.7% to $452 million, primarily due to the completion of the Medicaid unwinding exercise, which had previously inflated revenues.
Divestiture Charges Impact: Divestiture charges of approximately $38 million were incurred during the quarter, primarily due to foreign exchange losses, negatively impacting overall financial performance.
Negative Cash Flow Trends: Cash used in operating activities was $80 million, and free cash flow was an outflow of $103 million for the quarter, reflecting negative cash flow trends and operational inefficiencies.
Increased Leverage Concerns: The net debt to EBITDA ratio increased from 1.4 to 1.8 times, indicating a rise in leverage primarily due to increased share repurchase activity, which may raise concerns about financial stability.
Maximus, Inc. (NYSE:MMS) Q1 2025 Earnings Call Transcript
MMS.N
-1.14%